Glutamatergic Modulation to Facilitate the Behavioral Treatment of Cocaine Use Disorders
Sponsor: |
NIDA |
Enrolling: |
Male and Female Patients |
Study Length: |
12 Weeks |
IRB Number: |
7461-C |
U.S. Govt. ID: |
NCT03344419 |
Contact: |
HOPE Clinic: 646-854-9395 / hopeclinic@nyspi.columbia.edu |
This 12-week free and confidential outpatient study is recruiting healthy adults who are currently seeking treatment for cocaine use. Participants will engage in twice-weekly clinic visits during which they will have mindfulness-based therapy sessions, meet with a physician, and complete measures with research assistants. Participants will also receive innovative investigational medications twice throughout this trial (Weeks 1 and 5) to help facilitate their engagement in treatment. Upon completion of the study, participants will be referred to appropriate community providers to ensure that they have the necessary means to continue their progress.
This study is closed
Investigator
Elias Dakwar, MD
Is using cocaine a problem for you? |
Yes |
No |
Are you seeking treatment for your cocaine use? |
Yes |
No |